Deutsche medizinische Wochenschrift
-
Dtsch. Med. Wochenschr. · Aug 2000
Randomized Controlled Trial Comparative Study Clinical Trial[Terminating supraventricular tachycardia with adenosine--comparing the effectiveness of 12 mg and 18 mg].
This study was done to answer the question if intravenous application of 18 mg adenosine is superior to 12 mg adenosine for the termination of supraventricular tachycardias. ⋯ In AV nodal reentrant tachycardias and AV reentrant tachycardias with an accessory pathway, which can not be terminated by the administration of adenosine in a dose of 12 mg, the tachycardia can be terminated more effectively by the application of 18 mg adenosine.